Xylem (XYL) Stock After Dow Water System Deal Is The Undervaluation Case Taking Shape

Xylem (XYL) stock is back in focus after the company agreed to design, build, and operate a full-cycle water system for Dow’s industrial complex in Fort Saskatchewan, Alberta, under a long-term arrangement.

See our latest analysis for Xylem.

Despite the Dow agreement catching fresh attention, Xylem’s share price return has been under pressure, with the stock down 20.5% year to date and its 1 year total shareholder return declining 13.2%. This suggests momentum has been fading even as new projects emerge.

If this kind of industrial water story interests you, it can be useful to also look at grid focused infrastructure plays using our 34 power grid technology and infrastructure stocks

With Xylem’s stock under pressure despite new long-term projects and an indicated discount to some valuation estimates, the key question now is whether today’s weakness offers an entry point or if the market is already pricing in future growth.

Most Popular Narrative: 27.6% Undervalued

At a last close of $109.05 versus a narrative fair value of $150.65, the widely followed view frames Xylem as having a sizable valuation gap built on its long term water infrastructure role.

Significant and increasing investment in aging water infrastructure (notably in the U.S. and U.K.) underpins a strong multi-year backlog (> $5 billion). Anticipated order rebounds as funding cycles and regulatory timelines normalize support steady revenue growth and greater earnings visibility.

Read the complete narrative.

Want to see what is baked into that backlog story, and how it feeds into revenue, margins, and the future earnings multiple that underpins this fair value estimate.

Result: Fair Value of $150.65 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, the story can shift quickly if government infrastructure funding is delayed, or if China and other developing markets continue to weigh on orders and revenue visibility.

Find out about the key risks to this Xylem narrative.

Next Steps

If the combination of backlog optimism and recent share price weakness seems conflicting, take a closer look at the underlying drivers and decide promptly where you stand by reviewing the 6 key rewards.

Looking for more investment ideas?

If you are serious about building a stronger portfolio, do not stop at one stock. Use the Simply Wall Street Screener to uncover focused, data backed ideas.

• Target higher potential payouts by checking which companies currently stand out as income generators through the 8 dividend fortresses.
• Zero in on stocks that combine quality with attractive pricing by scanning the 46 high quality undervalued stocks for ideas that might deserve a closer look.
• Prioritize resilience by filtering for companies that show financial strength using the solid balance sheet and fundamentals stocks screener (47 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com